3.7.0.1 html 226 340 1 false 80 0 false 11 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://cumberlandpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://cumberlandpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://cumberlandpharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Income and Comprehensive Income (Loss) Sheet http://cumberlandpharma.com/role/ConsolidatedStatementsOfIncomeAndComprehensiveIncomeLoss Consolidated Statements of Income and Comprehensive Income (Loss) Statements 4 false false R5.htm 1003000 - Statement - Consolidated Statements of Cash Flows Sheet http://cumberlandpharma.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 1004000 - Statement - Consolidated Statements of Equity Sheet http://cumberlandpharma.com/role/ConsolidatedStatementsOfEquity Consolidated Statements of Equity Statements 6 false false R7.htm 2101100 - Disclosure - Organization Sheet http://cumberlandpharma.com/role/Organization Organization Notes 7 false false R8.htm 2101100 - Disclosure - Significant Accounting Policies Sheet http://cumberlandpharma.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate Sheet http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexate Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate Notes 9 false false R10.htm 2103100 - Disclosure - Revenues Sheet http://cumberlandpharma.com/role/Revenues Revenues Notes 10 false false R11.htm 2104100 - Disclosure - Inventories Sheet http://cumberlandpharma.com/role/Inventories Inventories Notes 11 false false R12.htm 2105100 - Disclosure - Property and Equipment Sheet http://cumberlandpharma.com/role/PropertyAndEquipment Property and Equipment Notes 12 false false R13.htm 2106100 - Disclosure - Intangible Assets Sheet http://cumberlandpharma.com/role/IntangibleAssets Intangible Assets Notes 13 false false R14.htm 2107100 - Disclosure - Other Current Liabilities Sheet http://cumberlandpharma.com/role/OtherCurrentLiabilities Other Current Liabilities Notes 14 false false R15.htm 2108100 - Disclosure - Debt Sheet http://cumberlandpharma.com/role/Debt Debt Notes 15 false false R16.htm 2109100 - Disclosure - Shareholders' Equity Sheet http://cumberlandpharma.com/role/ShareholdersEquity Shareholders' Equity Notes 16 false false R17.htm 2110100 - Disclosure - Earnings (Loss) Per Share Sheet http://cumberlandpharma.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 17 false false R18.htm 2111100 - Disclosure - Income Taxes Sheet http://cumberlandpharma.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2112100 - Disclosure - Stock-Based Compensation Plans Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlans Stock-Based Compensation Plans Notes 19 false false R20.htm 2113100 - Disclosure - Employee Benefit Plans Sheet http://cumberlandpharma.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 20 false false R21.htm 2114100 - Disclosure - Leases Sheet http://cumberlandpharma.com/role/Leases Leases Notes 21 false false R22.htm 2115100 - Disclosure - Fair Value of Financial Instruments Sheet http://cumberlandpharma.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 22 false false R23.htm 2116100 - Disclosure - Market Concentrations Sheet http://cumberlandpharma.com/role/MarketConcentrations Market Concentrations Notes 23 false false R24.htm 2117100 - Disclosure - Manufacturing and Supply Agreements Sheet http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreements Manufacturing and Supply Agreements Notes 24 false false R25.htm 2118100 - Disclosure - Employment Agreements Sheet http://cumberlandpharma.com/role/EmploymentAgreements Employment Agreements Notes 25 false false R26.htm 2119100 - Disclosure - Commitments and Contingencies Sheet http://cumberlandpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 26 false false R27.htm 2120100 - Disclosure - Quarterly Financial Information (Unaudited) Sheet http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnaudited Quarterly Financial Information (Unaudited) Notes 27 false false R28.htm 2122100 - Schedule - Valuation and Qualifying Accounts Sheet http://cumberlandpharma.com/role/ValuationAndQualifyingAccounts Valuation and Qualifying Accounts Uncategorized 28 false false R29.htm 2201201 - Disclosure - Significant Accounting Policies (Policies) Sheet http://cumberlandpharma.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Uncategorized 29 false false R30.htm 2301302 - Disclosure - Significant Accounting Policies (Tables) Sheet http://cumberlandpharma.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Uncategorized 30 false false R31.htm 2302301 - Disclosure - Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate (Tables) Sheet http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateTables Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate (Tables) Uncategorized 31 false false R32.htm 2303301 - Disclosure - Revenues (Tables) Sheet http://cumberlandpharma.com/role/RevenuesTables Revenues (Tables) Uncategorized 32 false false R33.htm 2304301 - Disclosure - Inventories (Tables) Sheet http://cumberlandpharma.com/role/InventoriesTables Inventories (Tables) Uncategorized 33 false false R34.htm 2305301 - Disclosure - Property and Equipment (Tables) Sheet http://cumberlandpharma.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Uncategorized 34 false false R35.htm 2306301 - Disclosure - Intangible Assets (Tables) Sheet http://cumberlandpharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Uncategorized 35 false false R36.htm 2307301 - Disclosure - Other Current Liabilities (Tables) Sheet http://cumberlandpharma.com/role/OtherCurrentLiabilitiesTables Other Current Liabilities (Tables) Uncategorized 36 false false R37.htm 2310301 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://cumberlandpharma.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Uncategorized 37 false false R38.htm 2311301 - Disclosure - Income Taxes (Tables) Sheet http://cumberlandpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Uncategorized 38 false false R39.htm 2312301 - Disclosure - Stock-Based Compensation Plans (Tables) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansTables Stock-Based Compensation Plans (Tables) Uncategorized 39 false false R40.htm 2314301 - Disclosure - Leases (Tables) Sheet http://cumberlandpharma.com/role/LeasesTables Leases (Tables) Uncategorized 40 false false R41.htm 2315301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Uncategorized 41 false false R42.htm 2316301 - Disclosure - Market Concentrations (Tables) Sheet http://cumberlandpharma.com/role/MarketConcentrationsTables Market Concentrations (Tables) Uncategorized 42 false false R43.htm 2320301 - Disclosure - Quarterly Financial Information (Unaudited) (Tables) Sheet http://cumberlandpharma.com/role/QuarterlyFinancialInformationUnauditedTables Quarterly Financial Information (Unaudited) (Tables) Uncategorized 43 false false R44.htm 2401401 - Disclosure - Organization (Narrative) (Details) Sheet http://cumberlandpharma.com/role/OrganizationNarrativeDetails Organization (Narrative) (Details) Uncategorized 44 false false R45.htm 2401403 - Disclosure - Significant Accounting Policies (Narrative) (Details) Sheet http://cumberlandpharma.com/role/SignificantAccountingPoliciesNarrativeDetails Significant Accounting Policies (Narrative) (Details) Uncategorized 45 false false R46.htm 2401404 - Disclosure - Significant Accounting Policies (Schedule of Intangible Assets, Useful Lives) (Details) Sheet http://cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleOfIntangibleAssetsUsefulLivesDetails Significant Accounting Policies (Schedule of Intangible Assets, Useful Lives) (Details) Uncategorized 46 false false R47.htm 2402402 - Disclosure - Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate - Narrative (Details) Sheet http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateNarrativeDetails Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate - Narrative (Details) Uncategorized 47 false false R48.htm 2402403 - Disclosure - Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate - Assets and Liabilities Assumed (Details) Sheet http://cumberlandpharma.com/role/VaprisolOmeclamoxPakEthyolAndMethotrexateAssetsAndLiabilitiesAssumedDetails Vaprisol, Omeclamox-Pak, Ethyol, and Methotrexate - Assets and Liabilities Assumed (Details) Uncategorized 48 false false R49.htm 2403402 - Disclosure - Revenues (Schedule of Net Product Revenues by Product) (Details) Sheet http://cumberlandpharma.com/role/RevenuesScheduleOfNetProductRevenuesByProductDetails Revenues (Schedule of Net Product Revenues by Product) (Details) Uncategorized 49 false false R50.htm 2403403 - Disclosure - Revenues (Narrative) (Details) Sheet http://cumberlandpharma.com/role/RevenuesNarrativeDetails Revenues (Narrative) (Details) Uncategorized 50 false false R51.htm 2404402 - Disclosure - Inventories (Schedule of Inventories, Current) (Details) Sheet http://cumberlandpharma.com/role/InventoriesScheduleOfInventoriesCurrentDetails Inventories (Schedule of Inventories, Current) (Details) Uncategorized 51 false false R52.htm 2404403 - Disclosure - Inventories (Narrative) (Details) Sheet http://cumberlandpharma.com/role/InventoriesNarrativeDetails Inventories (Narrative) (Details) Uncategorized 52 false false R53.htm 2405402 - Disclosure - Property and Equipment (Schedule of Property and Equipment) (Details) Sheet http://cumberlandpharma.com/role/PropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails Property and Equipment (Schedule of Property and Equipment) (Details) Uncategorized 53 false false R54.htm 2405403 - Disclosure - Property and Equipment (Narrative) (Details) Sheet http://cumberlandpharma.com/role/PropertyAndEquipmentNarrativeDetails Property and Equipment (Narrative) (Details) Uncategorized 54 false false R55.htm 2406402 - Disclosure - Intangible Assets (Schedule of Intangible Assets) (Details) Sheet http://cumberlandpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails Intangible Assets (Schedule of Intangible Assets) (Details) Uncategorized 55 false false R56.htm 2406403 - Disclosure - Intangible Assets (Narrative) (Details) Sheet http://cumberlandpharma.com/role/IntangibleAssetsNarrativeDetails Intangible Assets (Narrative) (Details) Uncategorized 56 false false R57.htm 2406404 - Disclosure - Intangible Assets Future Amortization Expense (Details) Sheet http://cumberlandpharma.com/role/IntangibleAssetsFutureAmortizationExpenseDetails Intangible Assets Future Amortization Expense (Details) Uncategorized 57 false false R58.htm 2407402 - Disclosure - Other Current Liabilities (Schedule of Accrued Liabilities) (Details) Sheet http://cumberlandpharma.com/role/OtherCurrentLiabilitiesScheduleOfAccruedLiabilitiesDetails Other Current Liabilities (Schedule of Accrued Liabilities) (Details) Uncategorized 58 false false R59.htm 2408401 - Disclosure - Debt (Line of Credit) (Details) Sheet http://cumberlandpharma.com/role/DebtLineOfCreditDetails Debt (Line of Credit) (Details) Uncategorized 59 false false R60.htm 2409401 - Disclosure - Shareholders' Equity (Initial Public Offering, Preferred Stock and Common Stock, Narrative) (Details) Sheet http://cumberlandpharma.com/role/ShareholdersEquityInitialPublicOfferingPreferredStockAndCommonStockNarrativeDetails Shareholders' Equity (Initial Public Offering, Preferred Stock and Common Stock, Narrative) (Details) Uncategorized 60 false false R61.htm 2409402 - Disclosure - Shareholders' Equity (Warrants, Narrative) (Details) Sheet http://cumberlandpharma.com/role/ShareholdersEquityWarrantsNarrativeDetails Shareholders' Equity (Warrants, Narrative) (Details) Uncategorized 61 false false R62.htm 2409403 - Disclosure - Shareholders' Equity (Share Repurchases, Cumberland Emerging Technologies, Narrative) (Details) Sheet http://cumberlandpharma.com/role/ShareholdersEquityShareRepurchasesCumberlandEmergingTechnologiesNarrativeDetails Shareholders' Equity (Share Repurchases, Cumberland Emerging Technologies, Narrative) (Details) Uncategorized 62 false false R63.htm 2410402 - Disclosure - Earnings (Loss) Per Share (Schedule of Computation of Numerator and Denominator in Earnings Per Share) (Details) Sheet http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfComputationOfNumeratorAndDenominatorInEarningsPerShareDetails Earnings (Loss) Per Share (Schedule of Computation of Numerator and Denominator in Earnings Per Share) (Details) Uncategorized 63 false false R64.htm 2410403 - Disclosure - Earnings (Loss) Per Share (Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share) (Details) Sheet http://cumberlandpharma.com/role/EarningsLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Earnings (Loss) Per Share (Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share) (Details) Uncategorized 64 false false R65.htm 2411402 - Disclosure - Income Taxes (Operating Loss Carryforwards, Narrative) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesOperatingLossCarryforwardsNarrativeDetails Income Taxes (Operating Loss Carryforwards, Narrative) (Details) Uncategorized 65 false false R66.htm 2411403 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities, Net) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesNetDetails Income Taxes (Schedule of Deferred Tax Assets and Liabilities, Net) (Details) Uncategorized 66 false false R67.htm 2411404 - Disclosure - Income Taxes (Schedule of Net Operating Loss Carryforwards) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesScheduleOfNetOperatingLossCarryforwardsDetails Income Taxes (Schedule of Net Operating Loss Carryforwards) (Details) Uncategorized 67 false false R68.htm 2411405 - Disclosure - Income Taxes (Schedule of the Components of Income Tax Benefit (Expense)) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxBenefitExpenseDetails Income Taxes (Schedule of the Components of Income Tax Benefit (Expense)) (Details) Uncategorized 68 false false R69.htm 2411406 - Disclosure - Income Taxes (Schedule of the Components of Deferred Income Tax Benefit (Expense)) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesScheduleOfComponentsOfDeferredIncomeTaxBenefitExpenseDetails Income Taxes (Schedule of the Components of Deferred Income Tax Benefit (Expense)) (Details) Uncategorized 69 false false R70.htm 2411407 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Sheet http://cumberlandpharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Uncategorized 70 false false R71.htm 2412402 - Disclosure - Stock-Based Compensation Plans (Narrative) (Details) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansNarrativeDetails Stock-Based Compensation Plans (Narrative) (Details) Uncategorized 71 false false R72.htm 2412403 - Disclosure - Stock-Based Compensation Plans (Schedule of Share-Based Compensation Expense) (Details) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfShareBasedCompensationExpenseDetails Stock-Based Compensation Plans (Schedule of Share-Based Compensation Expense) (Details) Uncategorized 72 false false R73.htm 2412404 - Disclosure - Stock-Based Compensation Plans (Schedule of Stock Options Activity) (Details) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionsActivityDetails Stock-Based Compensation Plans (Schedule of Stock Options Activity) (Details) Uncategorized 73 false false R74.htm 2412405 - Disclosure - Stock-Based Compensation Plans (Schedule of Stock Option Activity, Additional Disclosures) (Details) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfStockOptionActivityAdditionalDisclosuresDetails Stock-Based Compensation Plans (Schedule of Stock Option Activity, Additional Disclosures) (Details) Uncategorized 74 false false R75.htm 2412406 - Disclosure - Stock-Based Compensation Plans (Schedule of Restricted Stock Activity) (Details) Sheet http://cumberlandpharma.com/role/StockBasedCompensationPlansScheduleOfRestrictedStockActivityDetails Stock-Based Compensation Plans (Schedule of Restricted Stock Activity) (Details) Uncategorized 75 false false R76.htm 2413401 - Disclosure - Employee Benefit Plans (Narrative) (Details) Sheet http://cumberlandpharma.com/role/EmployeeBenefitPlansNarrativeDetails Employee Benefit Plans (Narrative) (Details) Uncategorized 76 false false R77.htm 2414402 - Disclosure - Leases (Narrative) (Details) Sheet http://cumberlandpharma.com/role/LeasesNarrativeDetails Leases (Narrative) (Details) Uncategorized 77 false false R78.htm 2414403 - Disclosure - Leases (Schedule of Future Minimum Rental Payments for Operating Leases) (Details) Sheet http://cumberlandpharma.com/role/LeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails Leases (Schedule of Future Minimum Rental Payments for Operating Leases) (Details) Uncategorized 78 false false R79.htm 2415402 - Disclosure - Fair Value of Financial Instruments (Schedule of Fair Value of Financial Instruments by Level in Hierarchy and Narrative) (Details) Sheet http://cumberlandpharma.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsByLevelInHierarchyAndNarrativeDetails Fair Value of Financial Instruments (Schedule of Fair Value of Financial Instruments by Level in Hierarchy and Narrative) (Details) Uncategorized 79 false false R80.htm 2416402 - Disclosure - Market Concentrations (Schedule of Revenues Concentration from Major Customers and Narrative) (Details) Sheet http://cumberlandpharma.com/role/MarketConcentrationsScheduleOfRevenuesConcentrationFromMajorCustomersAndNarrativeDetails Market Concentrations (Schedule of Revenues Concentration from Major Customers and Narrative) (Details) Uncategorized 80 false false R81.htm 2417401 - Disclosure - Manufacturing and Supply Agreements Manufacturing and Supply Agreements (Narrative) (Details) Sheet http://cumberlandpharma.com/role/ManufacturingAndSupplyAgreementsManufacturingAndSupplyAgreementsNarrativeDetails Manufacturing and Supply Agreements Manufacturing and Supply Agreements (Narrative) (Details) Uncategorized 81 false false R82.htm 2419401 - Disclosure - Commitments and Contingencies (Legal Matters, Narrative) (Details) Sheet http://cumberlandpharma.com/role/CommitmentsAndContingenciesLegalMattersNarrativeDetails Commitments and Contingencies (Legal Matters, Narrative) (Details) Uncategorized 82 false false R83.htm 2420402 - Disclosure - Quarterly Financial Information (Schedule of Quarterly Financial Information (Unaudited)) (Details) Sheet http://cumberlandpharma.com/role/QuarterlyFinancialInformationScheduleOfQuarterlyFinancialInformationUnauditedDetails Quarterly Financial Information (Schedule of Quarterly Financial Information (Unaudited)) (Details) Uncategorized 83 false false R84.htm 2422401 - Disclosure - Valuation and Qualifying Accounts (Details) Sheet http://cumberlandpharma.com/role/ValuationAndQualifyingAccountsDetails Valuation and Qualifying Accounts (Details) Uncategorized 84 false false All Reports Book All Reports cpix-20161231.xml cpix-20161231.xsd cpix-20161231_cal.xml cpix-20161231_def.xml cpix-20161231_lab.xml cpix-20161231_pre.xml true true